Leaderboards · Health Care › Pharmaceuticals

Pharmaceuticals · Large-cap

25 shown

#	Company	Score	Growth	Margin	Mkt cap	F
1	ARWRARROWHEAD PHARMACEUTICALS, INC.	100	23258%	-44%	$11.8B	—
2	MDGLMADRIGAL PHARMACEUTICALS, INC.	97	432%	-27%	$12.2B	—
3	ASNDAscendis Pharma A/S	94	98%	-32%	$18.0B	—
4	ALNYALNYLAM PHARMACEUTICALS, INC.	91	65%	8%	$41.8B	6
5	LLYELI LILLY & Co	88	45%	32%	$1.1T	8
6	AXSMAxsome Therapeutics, Inc.	85	66%	-27%	$12.6B	—
7	ONCBeOne Medicines Ltd.	82	40%	5%	$30.9B	7
8	BBIOBridgeBio Pharma, Inc.	79	126%	-126%	$15.1B	2
9	RPRXRoyalty Pharma plc	76	5%	56%	$25.6B	—
10	UTHRUNITED THERAPEUTICS Corp	73	11%	41%	$23.6B	8
11	GMABGENMAB A/S	70	19%	26%	$17.5B	—
12	VRTXVERTEX PHARMACEUTICALS INC / MA	67	9%	36%	$134.0B	6
13	NVONOVO NORDISK A S	64	6%	33%	$223.2B	—
14	RDYDR REDDYS LABORATORIES LTD	61	14%	18%	$12.0B	—
15	ZTSZoetis Inc.	58	2%	28%	$31.4B	6
16	REGNREGENERON PHARMACEUTICALS, INC.	55	1%	30%	$68.6B	—
17	JNJJOHNSON & JOHNSON	52	6%	22%	$633.2B	4
18	AZNASTRAZENECA PLC	48	9%	17%	$302.7B	—
19	BMRNBIOMARIN PHARMACEUTICAL INC	45	13%	8%	$11.4B	4
20	GSKGSK plc	42	4%	19%	$107.5B	—
21	ABTABBOTT LABORATORIES	39	6%	14%	$166.2B	5
22	IONSIONIS PHARMACEUTICALS INC	36	34%	-31%	$13.5B	3
23	ABBVAbbVie Inc.	33	9%	6%	$461.3B	7
24	MRKMerck & Co., Inc.	30	1%	14%	$320.0B	4
25	TEVATEVA PHARMACEUTICAL INDUSTRIES LTD	27	4%	8%	$40.3B	8

Ranked by percentile of (0.6 × revenue growth + 0.4 × net margin) within the Pharmaceuticals · large-cap cohort (34 companies). Score 0–100. Click a column to re-sort; Best/Worst flip the cohort ranking.